Biotech Five Prime Therapeutics News

Five Prime Therapeutics CEO Aron Knickerbocker is Leaving the Company

Biotech News | 20.09.2019

Aron Knickerbocker, CEO of the San Francisco-based immune-oncology firm Five Prime Therapeutics, is...